Jacinth Fairley
Director/Board Member bei MIRRABOOKA INVESTMENTS LIMITED
Vermögen: 425 311 $ am 31.03.2024
Profil
Jacinth K.
Fairley is an Independent Non-Executive Director at Mirrabooka Investments Ltd.
She was previously the Chief Executive Officer, MD & Executive Director at Starpharma Holdings Ltd.
from 2006 to 2024.
She was also the Director at Melbourne Business School from 2010 to 2020.
Additionally, she is a Member of the Pharmaceutical Industry Working Group.
Fairley holds an MBA from Melbourne Business School and an undergraduate degree from the University of Melbourne.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 06.10.2023 | 4 055 434 ( 0,98% ) | 330 721 $ | 31.03.2024 | |
| 19.02.2024 | 43 540 ( 0,02% ) | 94 590 $ | 31.03.2024 |
Aktive Positionen von Jacinth Fairley
| Unternehmen | Position | Beginn |
|---|---|---|
| MIRRABOOKA INVESTMENTS LIMITED | Director/Board Member | 15.02.2018 |
Ehemalige bekannte Positionen von Jacinth Fairley
| Unternehmen | Position | Ende |
|---|---|---|
| STARPHARMA HOLDINGS LIMITED | Chief Executive Officer | 08.01.2024 |
| Melbourne Business School | Director/Board Member | 01.12.2020 |
| Pharmaceutical Industry Working Group | Corporate Officer/Principal | - |
Ausbildung von Jacinth Fairley
| Melbourne Business School | Masters Business Admin |
| University of Melbourne | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| STARPHARMA HOLDINGS LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Mirrabooka Investments Ltd.
 Mirrabooka Investments Ltd. Investment Trusts/Mutual FundsMiscellaneous Mirrabooka Investments Ltd. is closed-end investment fund/Investment trust. It invests in small and medium sized companies located in Australia and New Zealand. The company was founded in December 1998 and is headquartered in Melbourne, Australia. | Miscellaneous |
| Pharmaceutical Industry Working Group |
